info@mail.ucallm.com
1. Overview
The yeast expression system is a premier eukaryotic platform for recombinant protein production, combining the ease of genetic manipulation of prokaryotic systems with many of the post-translational modification (PTM) capabilities of eukaryotic cells. As unicellular eukaryotic microorganisms, yeasts not only exhibit rapid growth and straightforward genetic manipulation but also possess organelles such as the endoplasmic reticulum and Golgi apparatus, enabling proper protein folding and PTMs.
The currently predominant yeast expression systems include Komagataella phaffii（formerly Pichia pastoris） and Saccharomyces cerevisiae. As a methylotrophic yeast, P. pastoris offers high expression levels, genetic stability, robust secretion capacity, and well-established fermentation processes. For some target proteins, recombinant protein yield may be 10–100-fold higher than that of S. cerevisiae. S. cerevisiae, with the longest history of application, is widely used as a cloning or expression host in genetic engineering.
2. Core Advantages
(1) High expression levels: Recombinant protein may account for more than 30% of total soluble protein under optimized conditions; yields in P. pastoris are 10-100 times higher than in S. cerevisiae.
(2) Eukaryotic folding and basic PTMs: Eukaryotic nature ensures proper protein folding and PTMs including disulfide bond formation, glycosylation, proteolytic processing, and some phosphorylation events.
(3) Secretory expression: Signal peptides direct recombinant proteins into the extracellular medium, greatly simplifying downstream purification
(4) Ease of genetic manipulation: Offers convenience comparable to E. coli
(5) Low culture cost: Capable of high-density cultivation in simple, inexpensive media
(6) Safety: Yeasts do not produce endotoxins and many industrial yeast species are Generally Recognized As Safe (GRAS)
(7) Genetic stability: Integrative vectors enable stable chromosomal integration of exogenous genes
(8) Industrial suitability: Well-established fermentation processes are easily scalable from laboratory to industrial production.
3. System Limitations
(1) Glycosylation differences: Yeasts primarily perform high-mannose type glycosylation, lacking mammalian-type complex glycosylation and terminal sialylation, which may affect protein function and immunogenicity.
(2) Hypermannosylation: Some yeasts (e.g., S. cerevisiae) exhibit hypermannosylation during secretory expression, which can mask functional epitopes.
(3) Low secretion efficiency: Secretion efficiency for certain proteins may be low, impacting yield
(4) Protein degradation and heterogeneity: Incomplete signal peptide processing and extracellular/intracellular proteolysis may lead to product heterogeneity and active yield loss.
(5) Misfolding: Some large or multidomain proteins may fold inefficiently
(6) Methanol safety: The AOX1 promoter system requires methanol induction, which is toxic and flammable.
4. Key Application Areas
(1) Basic research: Production of recombinant proteins for structural and functional studies, e.g., Green Fluorescent Protein for labeling, kinases for signaling pathway research
(2) Industrial enzyme production: Proteases, lipases, amylases, etc., e.g., alkaline protease for detergents, glucose isomerase for food processing.
(3) Therapeutic proteins: Insulin, growth hormones, etc.
(4) Diagnostic reagents: Antigens, antibodies, and enzyme labels, e.g., HIV p24 antigen for HIV diagnostics
(5) Vaccine development: Recombinant subunit vaccines, e.g., HPV L1 virus-like particles (VLPs) for cervical cancer prevention
5. Classification of Expression Vectors
5.1 By basic yeast vector types
Type | Features | Vector |
Integrative vectors | Integrate into yeast chromosomes via homologous recombination; cannot replicate autonomously | YIp |
Autonomously replicating vectors | Contain yeast autonomous replicating sequence ; relatively unstable without selection pressure | YRp |
Contain endogenous plasmid origin of replication; high copy number | YEp | |
Contain centromere sequence; low copy number but genetically stable | YCp |
5.2 By host system
(1) P. pastoris expression vectors
All are integrative vectors, requiring homologous recombination for chromosomal integration.
Type | Features | Representative vectors |
Secretory vectors | Carry signal peptides (e.g., α-mating factor (α-factor)) for secretion | pPIC9, pPIC9K, pPICZα |
Intracellular vectors | Lack signal peptide; protein accumulates in the cytoplasm | pPIC3.5, pPIC3.5K, pPICZ |
Multi-copy integration vectors | Allow selection of multicopy genomic integrants for multi-copy integration to enhance expression | pPIC9K |
Constitutive promoter vectors | Carry GAP promoter for expression without inducers | pGAPZ, pGAPα |
Inducible promoter vectors | Carry AOX1 promoter requiring methanol induction | pPIC, pPICZ |
(2) S. cerevisiae expression vectors
Include both integrative and autonomously replicating types. Commonly used promoters include GAL1, PGK1, TEF1/TEF2, ADH1, and GPD.
(3) Comparison:P. pastoris vs S. cerevisiae
Feature | P. pastoris | S. cerevisiae |
Expression level | High | Moderate |
Glycosylation pattern | Predominantly high-mannose but generally shorter glycans than S. cerevisiae; lower immunogenicity | High-mannose; hyperglycosylation |
Secretion capacity | Strong; high secretory yield | Moderate |
Genetic manipulation | Mature; primarily integrative | Very mature; rich vector variety |
Fermentation process | Mature; high-density culture achievable | Very mature |
Induction method | Methanol (AOX1) or constitutive (GAP) | Galactose or constitutive |
Applications | Therapeutic proteins, industrial enzymes | Basic research, small proteins |
Selection Recommendations: For high expression, secretory expression, and industrial-scale recombinant protein production, P. pastoris is preferred. For basic research, vector construction/screening, and small protein expression, S. cerevisiae remains the classic choice.
6. Common P. pastoris Host Strains
Strain | Genotype | Phenotype | Features | Applications |
X33 | Wild-type | Mut+ His+ | intact AOX1; normal methanol utilization; higher transformation efficiency | Protein expression without auxotrophic selection |
GS115 | his4 | Mut+ His- | his4 mutation; requires histidine; intact AOX1 | Expression with histidine auxotrophic selection |
KM71 | his4, arg4, aox1::ARG4 | MutS His- | AOX1 disrupted; slow methanol utilization (MutS) | Reduced methanol utilization may improve folding for some proteins; histidine selection |
KM71H | aox1::ARG4, arg4 | MutS His+ | AOX1 disrupted; all transformants are MutS | Slow methanol utilization; no need to screen Mut phenotype |
SMD1168 | his4, pep4 | Mut+ His- | Protease A deficient | Expression of protease-susceptible proteins; histidine selection |
SMD1168H | pep4 | Mut+ His+ | Protease A deficient | Expression of protease-susceptible proteins |
7. Selection Guide
Requirement | Recommended Vector/System | Reason |
High-level secretory protein | pPIC9K / pPICZα + P. pastoris) | Strong AOX1 induction; efficient α-factor signal peptide |
Constitutive expression (no induction) | pGAPZ + P. pastoris) | GAP constitutive promoter; simple operation |
Intracellular expression | pPIC3.5K/pPICZ + P. pastoris | No signal peptide; protein accumulates intracellularly |
Multi-copy integration for high yield | pPIC9K + P. pastoris | Selection with increasing concentrations of Zeocin or G418 for multicopy integrants (depending on vector) |
Basic research in S. cerevisiae | YEp/YCp vectors | Rich vector variety; mature genetic tools |
Galactose-inducible expression | YEp + GAL1 promoter | Tight regulation; classic inducible system |
Host Strain & Vector Matching:
l GS115 + pPIC9K/pPIC3.5K: The most classic combination for most P. pastoris projects
l X33 + pPICZ/pPICZα: Ideal when auxotrophic selection is not required.
l KM71H + pPICZ/pPICZα: Suitable for slow methanol utilization scenarios
l SMD1168 + vectors carrying HIS4 marker: Best for expressing protease-susceptible proteins
8. Service Highlights
l High-Yield Guarantee: Leveraging our extensive experience, we have successfully achieved gram-per-liter recombinant protein production for selected targets
l Multiple Host Options: X33, GS115, KM71H, and more to meet diverse expression needs
l Versatile Vector Systems: pPIC9K, pPICZα, pGAPZ, etc., supporting secretory, intracellular, constitutive, and inducible expression
l Gene-to-Protein Solution: Complete service from codon optimization, gene synthesis, and vector construction to protein purification
l Industrial Scalability: Mature fermentation processes enable seamless scale-up from lab to pilot- and industrial-scale fermentation.
9. Service Procedure
Service Step | Gene synthesis and vector construction (Optional) | Expression evaluation and optimization | Large-scale expression and purification |
Description | l Provide protein/gene sequence or plasmid l Codon optimization l Cloning into expression vectors l Plasmid validation & preparation | l Transformation into the selected yeast host l Pilot expression & purification trial l Protein expression evaluation (SDS-PAGE) | l Large-scale expression & purification l QC analysis
|
Deliverables | l Plasmid sequence l COA report | l Expression evaluation result | l Purified proteins l COA report |
Turnaround Times | 2-3 weeks | 4-5 weeks | 2-3 weeks |
10. Case Studies
11. Frequently Asked Questions (FAQs)
l Q1: Should I choose intracellular or secretory expression for my protein?
A: Intracellular expression is suitable for proteins that fold correctly in the cytoplasm and require simpler downstream processing. Secretory expression is recommended for proteins with multiple disulfide bonds, those prone to degradation, or to simplify purification.
l Q2: Why is my protein not expressed in P. pastoris?
A: Possible reasons include codon usage bias, inefficient signal peptide cleavage, protein toxicity to the host, or suboptimal culture/induction conditions. We offer codon optimization and condition screening services.
l Q3: What are the advantages of P. pastoris over CHO cells?
A: P. pastoris offers faster growth, lower media costs, and simpler handling, making it cost-effective for rapid, large-scale production. However, its glycosylation pattern differs from mammalian cells. For proteins that do not require complex human-like glycosylation, P. pastoris is an excellent choice. For clinical applications requiring humanized glycoforms, we offer glycoengineered yeast platforms (e.g., GlycoSwitch) to meet your needs.